- Home
- RNGR vs CDTX Comparison
RNGR vs CDTX Comparison
Compare RNGR & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNGR
- CDTX
- Stock Information
- Founded
- RNGR 2017
- CDTX 2012
- Country
- RNGR United States
- CDTX United States
- Employees
- RNGR N/A
- CDTX N/A
- Industry
- RNGR Oilfield Services/Equipment
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RNGR Energy
- CDTX Health Care
- Exchange
- RNGR Nasdaq
- CDTX Nasdaq
- Market Cap
- RNGR 279.8M
- CDTX 259.0M
- IPO Year
- RNGR 2017
- CDTX 2015
- Fundamental
- Price
- RNGR $11.21
- CDTX $19.15
- Analyst Decision
- RNGR Hold
- CDTX Strong Buy
- Analyst Count
- RNGR 2
- CDTX 8
- Target Price
- RNGR $12.50
- CDTX $38.00
- AVG Volume (30 Days)
- RNGR 118.5K
- CDTX 108.4K
- Earning Date
- RNGR 04-29-2025
- CDTX 05-08-2025
- Dividend Yield
- RNGR 2.14%
- CDTX N/A
- EPS Growth
- RNGR 27.70
- CDTX N/A
- EPS
- RNGR 0.87
- CDTX N/A
- Revenue
- RNGR $569,400,000.00
- CDTX $1,275,000.00
- Revenue This Year
- RNGR $11.70
- CDTX N/A
- Revenue Next Year
- RNGR N/A
- CDTX N/A
- P/E Ratio
- RNGR $12.77
- CDTX N/A
- Revenue Growth
- RNGR N/A
- CDTX N/A
- 52 Week Low
- RNGR $9.27
- CDTX $10.14
- 52 Week High
- RNGR $18.45
- CDTX $28.42
- Technical
- Relative Strength Index (RSI)
- RNGR 37.16
- CDTX 42.23
- Support Level
- RNGR $11.05
- CDTX $19.97
- Resistance Level
- RNGR $12.39
- CDTX $22.80
- Average True Range (ATR)
- RNGR 0.60
- CDTX 1.42
- MACD
- RNGR -0.01
- CDTX -0.13
- Stochastic Oscillator
- RNGR 24.06
- CDTX 9.49
About RNGR Ranger Energy Services Inc.
Ranger Energy Services Inc is a provider of onshore high-specification (high-spec) well service rigs, wireline services, and additional processing solutions and ancillary services in the United States. It offers a range of well-site services to U.S. exploration and production (E&P) companies that are fundamental to establishing and enhancing the flow of oil and natural gas throughout the productive life of a well. The segments of the group are High Specification Rigs, Wireline Services and Processing Solutions, and Ancillary Services, of which key revenue is derived from the High Specification Rigs segment.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.